University of Texas Health Science Center Houston


Mission Statement

The goal of the Center for Clinical and Translational Sciences (CCTS) is to facilitate clinical and translational research at The University of Texas Health Science Center at Houston (UTHealth), The University of Texas M. D. Anderson Cancer Center, and the Memorial Hermann Hospital System.

At a Glance


Educational Resources Posted


Consortium News Stories Posted


Events Posted


Opportunities Posted


Publications citing CTSA Program Grant


Users from Hub Registered

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2016, 2019 - 2021


The newly established UTHealth Institute for Implementation Science seeks a candidate who demonstrates interest and expertise in interdisciplinary implementation science. Under the supervision and mentorship of UTHealth Institute for Implementation Directors Bijal Balasubramanian, M.B.B.S, PhD & Maria E. Fernandez, PhD, the Postdoctoral Research Fellow will participate in, design, organize and

The Center for Clinical and Translational Sciences (CCTS) was the nation’s first multi-institutional Clinical and Translational Science Award (CTSA) program. The CCTS was funded in 2006 in the first class of CTSAs and was originally a collaboration in Houston between The University of Texas Health Science Center at Houston (UTHSC-H) and The University of Texas M. D. Anderson Cancer Center (UT
Performs grant program development, application, administration and reporting for the Center for Clinical and Translational Sciences. Works closely with Director, Center for Clinical and Translational Sciences (CCTS) Grant Programs and other CCTS staff on scientific and administrative aspects of the CCTS. Assists in writing grant proposals to both private foundations and governmental agencies. May

Poster Sessions

University Of Texas Hlth Sci Ctr Houston

Clinical and research data are increasingly collected and aggregated in clinical data warehouses (CDWs). Access to these data is subject to local, state and national regulations. For multiple reasons, institutions differ in how they interpret and apply these regulations. Sometimes, inter-institutional differences are unavoidable, such as when regulations clearly require specific practices. However

University Of Texas Hlth Sci Ctr Houston

There has been a true revolution in cancer treatment. Numerous genetic alterations are being targeted using new therapies with the potential for improved, less toxic – often durable - outcomes in advanced cancer. Response rates are 3-5% for unmatched treatment with new tyrosine kinases and other similar agents whereas a “high value” alteration can result in response rates of 30-50% for actionable

Learning Healthcare: An Ongoing Paradigm Shift
University Of Texas Hlth Sci Ctr Houston

Learning healthcare (LHC) incorporates learning seamlessly into everyday patient care and is crucial to rapidly advancing patient outcomes and ultimately population health. Observational studies are valuable in generating new hypotheses and identifying highly effective therapies (resulting in a published relative risk for adverse outcome <0.10 compared to placebo or usual care). However, the great


Understanding enterprise data warehouses to support clinical and translational research: enterprise information technology relationships, data governance, workforce, and cloud computing

Objective Among National Institutes of Health Clinical and Translational Science Award (CTSA) hubs, effective approaches for enterprise data warehouses for research (EDW4R) development, maintenance, and sustainability remain unclear. The goal of this qualitative study was to understand CTSA EDW4R

Artificial intelligence in Clinical and Translational Science: Successes, Challenges and Opportunities

Artificial intelligence (AI) is transforming many domains, including finance, agriculture, defense, and biomedicine. In this paper, we focus on the role of AI in clinical and translational research (CTR), including preclinical research (T1), clinical research (T2), clinical implementation (T3), and

Associations of Metabolic Genes (GSTT1, GSTP1, GSTM1) and Blood Mercury Concentrations Differ in Jamaican Children with and without Autism Spectrum Disorder

We investigated interactive roles of three metabolic glutathione S-transferase (GST) genes (GSTP1, GSTT1, and GSTM1) and autism spectrum disorder (ASD) status in relation to blood Hg concentrations (BHC) of Jamaican children. We used data from 266 children (2-8 years) with ASD and their 1:1 age- and